Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation
β Scribed by Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Young-Dong Yu; Pyoung-Jae Park; Young-Il Choi; Kyoung-Won Kim; Young-Suk Lim; Han Chu Lee; Eun-Sil Yu; Sung-Gyu Lee
- Book ID
- 107412137
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 350 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1091-255X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Criteria for the selection of candidates for liver transplantation in the presence of hepatocellular carcinoma (HCC) should accurately predict posttransplant recurrence while not excluding excessive numbers of patients from candidacy. Existing criteria are challenged by the limited accuracy of radio
## Abstract ## Background and Objectives Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains a major cause of postβLT death. However, currently there is still lacking the markers to reliably predict recurrence. This study was undertaken to evaluate the association
be either higher or lower than 1, i.e., having serological mark-to the exposure of interest, constitute a valid and well-accepted comparison group, which has been used in countless ers of infection by hepatitis B and C viruses could be either ''protective'' or ''predisposing'' factors for aplastic a
To confirm recent observations about the relationship between immunosuppression and the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), we retrospectively analyzed 70 consecutive HCC patients who underwent LT and received cyclosporine (CsA) -based immunosuppression. Cs
In the present study, the results of living donor liver transplantation (LDLT) for 125 hepatocellular carcinoma (HCC) patients were analyzed to determine optimal criteria exceeding the Milan criteria (MC) but still with predictably good outcomes. On the basis of pretransplant imaging studies, 70 pat